The US FDA has approved GSK’s Hibsago for chronic hepatitis B, with 19% of trial participants achieving a functional cure.
Shanghai, China - October 16, 2026 - MicroPort Scientific Corporation announced that it and its associated companies have reached a cumulative total of 50 products accepted into China's National ...
New MD Anderson studies report a Phase 3 immunotherapy advance in EGFR-mutant lung cancer, a dual role for B7-H3 in prostate ...
An Indian clinical trial published in The Lancet found that an eight-week course of antiviral drugs cured nearly 99% of ...
The 13-point charter also called for the restoration of GSCASH, the return of JNUEE and action on wider concerns over campus ...
Spread the love“`html Google’s recent strides in artificial intelligence, particularly in the medical field, have been nothing short of breathtaking. We’re talking about AI systems that can achieve ...
Eli Lilly and Company announced that new data from across its oncology portfolio will be presented at the European Society for Medical Oncology Congress, taking place October 23?27 in Madrid, Spain.
Pills that rival biologics, weight-loss drugs paired with psoriasis treatment and a phase 3 win for a personalized mRNA ...
Recently, the talk show 'A Question of Science,' produced by the Francis Crick Institute in London, released an episode ...
Detailed price information for Nuvectis Pharma Inc (NVCT-Q) from The Globe and Mail including charting and trades.
SeaStar Medical Holding Corp. ( ICU ), a commercial-stage healthcare company, said the U.S. FDA has granted Breakthrough Device Designation to its Selective Cytopheretic Device (SCD) therapy for ...
Three changes show what AI is already doing to everyday care. For someone with diabetes, an automated insulin delivery system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results